Lynsey M. Cree

Lynsey M. Cree

Auto-generated profile, based on publicly available information

Lynsey M. Cree

University of Auckland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2008 in Nature Genetics
Verified
Journal Article
Closed access
LCLynsey M Cree
Lynsey M Cree
DSDavid C. Samuels
David C. Samuels
SLSusana Chuva de Sousa Lopes
Susana Chuva de Sousa Lopes
HRHarsha Karur Rajasimha
Harsha Karur Rajasimha
PWPassorn Wonnapinij
Passorn Wonnapinij
PCPatrick F Chinnery
Patrick F Chinnery

14 April 2010 in Nature
Verified
Journal Article
Open access
PDF file
LCLyndsey Craven
Lyndsey Craven
HTHelen A. Tuppen
Helen A. Tuppen
GGGareth D. Greggains
Gareth D. Greggains
SHStephen J. Harbottle
Stephen J. Harbottle
JMJulie L. Murphy
Julie L. Murphy
DTDouglass M. Turnbull
Douglass M. Turnbull
Mitochondrial DNA (mtDNA) mutations passed down from a mother to offspring are a common cause of genetic disease, including neurological, muscle and heart problems, deafness and type 2 diabetes. It was shown recently in non-human primates that nuclear transfer techniques can prevent their transmission. Now, that proof-of-principle work has been extended to human embryos (see News, http://go.nature.com/xqgWXf ). A multi-department team based at Newcastle University transferred pronuclei between human zygotes, and obtained onward development to the blastocyst stage in vitro. Carry-over of donor zygote mtDNA is minimal, so the technique could potentially prevent the transmission of mtDNA disease in humans. Mutations in mitochondrial DNA (mtDNA) are a common cause of human genetic disease. It has been shown in non-human primates that nuclear transfer techniques might be an approach to prevent the transmission of mtDNA mutations. The proof of principle has now been extended to human embryos. Pronuclei were transferred between human zygotes, which developed onwards to the blastocyst stage in vitro. Carry-over of mtDNA from the donor zygotes to the recipients was minimal. Mutations in mitochondrial DNA (mtDNA) are a common cause of genetic disease. Pathogenic mutations in mtDNA are detected in approximately 1 in 250 live births1,2,3 and at least 1 in 10,000 adults in the UK are affected by mtDNA disease4. Treatment options for patients with mtDNA disease are extremely limited and are predominantly supportive in nature. Mitochondrial DNA is transmitted maternally and it has been proposed that nuclear transfer techniques may be an approach for the prevention of transmission of human mtDNA disease5,6. Here we show that transfer of pronuclei between abnormally fertilized human zygotes results in minimal carry-over of donor zygote mtDNA and is compatible with onward development to the blastocyst stage in vitro. By optimizing the procedure we found the average level of carry-over after transfer of two pronuclei is less than 2.0%, with many of the embryos containing no detectable donor mtDNA. We believe that pronuclear transfer between zygotes, as well as the recently described metaphase II spindle transfer, has the potential to prevent the transmission of mtDNA disease in humans.

22 April 2003 in Neurology
Verified
Journal Article
Closed access
PDF file
MPM. Poppe
M. Poppe
LCL. Cree
L. Cree
JBJ. Bourke
J. Bourke
MEM. Eagle
M. Eagle
LAL.V.B. Anderson
L.V.B. Anderson
KBK. Bushby
K. Bushby
Background: Mutations in the fukutin-related protein gene FKRP cause limb-girdle muscular dystrophy (LGMD2I) as well as a form of congenital muscular dystrophy (MDC1C). Objective: To define the phenotype in LGMD2I. Methods: The authors assessed 16 patients from 14 families with FKRP gene mutations and LGMD and collected the results of mutation analysis, protein studies, and respiratory and cardiac investigations. Results: Thirteen patients, most with adult presentation, were homozygous for the common C826A mutation in FKRP. The three other cases were compound heterozygotes for C826A and two of them presented in childhood, with more progressive disease. The pattern of muscle involvement, frequently including calf hypertrophy, was similar to dystrophinopathy. Complications in patients with LGMD2I were common and sometimes out of proportion to the skeletal muscle involvement. Six patients had cardiac involvement, and 10 had respiratory impairment: five required nocturnal respiratory support. All patients had serum creatine kinase at least 5 to 70 times normal. The most consistent protein abnormality found on muscle biopsy was a reduction of laminin α2 immunolabeling, either on muscle sections or immunoblotting alone. Conclusions: LGMD2I due to FKRP mutations appears to be a relatively common cause of LGMD, with respiratory and cardiac failure as prominent complications.

7 October 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CFChristoph Freyer
Christoph Freyer
LCLynsey M Cree
Lynsey M Cree
AMArnaud Mourier
Arnaud Mourier
JSJames B Stewart
James B Stewart
CKCamilla Koolmeister
Camilla Koolmeister
PCPatrick F Chinnery
Patrick F Chinnery
Patrick Chinnery, Nils-Goran Larsson and colleagues show that mitochondrial heteroplasmy levels are principally determined prenatally within the developing female germline in mice transmitting a heteroplasmic single base-pair deletion in the mitochondrial tRNAMet gene. A genetic bottleneck explains the marked changes in mitochondrial DNA (mtDNA) heteroplasmy that are observed during the transmission of pathogenic mutations, but the precise timing of these changes remains controversial, and it is not clear whether selection has a role. These issues are important for the genetic counseling of prospective mothers and for the development of treatments aimed at disease prevention. By studying mice transmitting a heteroplasmic single-base-pair deletion in the mitochondrial tRNAMet gene, we show that the extent of mammalian mtDNA heteroplasmy is principally determined prenatally within the developing female germline. Although we saw no evidence of mtDNA selection prenatally, skewed heteroplasmy levels were observed in the offspring of the next generation, consistent with purifying selection. High percentages of mtDNA genomes with the tRNAMet mutation were linked to a compensatory increase in overall mitochondrial RNA levels, ameliorating the biochemical phenotype and explaining why fecundity is not compromised.

1 January 2017 in Fertility and Sterility
Verified
Journal Article
Closed access
EHElizabeth R. Hammond
Elizabeth R. Hammond
BMBrent C. McGillivray
Brent C. McGillivray
SWSophie M. Wicker
Sophie M. Wicker
JPJohn C. Peek
John C. Peek
ASAndrew N. Shelling
Andrew N. Shelling
LCLynsey M. Cree
Lynsey M. Cree

1 July 2007 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SDSteve E. Durham
Steve E. Durham
DSDavid C. Samuels
David C. Samuels
LCLynsey M. Cree
Lynsey M. Cree
PCPatrick F. Chinnery
Patrick F. Chinnery